Vanguard Group’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$12.8M Buy
2,089,641
+204,036
+11% +$2.2M ﹤0.01% 2839
2025
Q3
$34.8M Buy
1,885,605
+75,440
+4% +$1.21M ﹤0.01% 2334
2025
Q2
$23.6M Buy
1,810,165
+61,237
+4% +$724K ﹤0.01% 2484
2025
Q1
$18.5M Buy
1,748,928
+64,367
+4% +$1.02M ﹤0.01% 2538
2024
Q4
$28.6M Buy
1,684,561
+107,635
+7% +$2.03M ﹤0.01% 2414
2024
Q3
$36.6M Buy
1,576,926
+192,182
+14% +$4.11M ﹤0.01% 2313
2024
Q2
$33.7M Sell
1,384,744
-3,150
-0.2% -$95.5K ﹤0.01% 2309
2024
Q1
$46.9M Sell
1,387,894
-70,486
-5% -$2.5M ﹤0.01% 2202
2023
Q4
$46M Buy
1,458,380
+51,537
+4% +$1.22M ﹤0.01% 2223
2023
Q3
$35.9M Sell
1,406,843
-221,573
-14% -$6.83M ﹤0.01% 2285
2023
Q2
$46.7M Buy
1,628,416
+163,070
+11% +$4.44M ﹤0.01% 2216
2023
Q1
$35.1M Buy
1,465,346
+14,921
+1% +$268K ﹤0.01% 2340
2022
Q4
$24.6M Buy
1,450,425
+113,607
+8% +$1.98M ﹤0.01% 2528
2022
Q3
$19.8M Buy
1,336,818
+143,162
+12% +$2.4M ﹤0.01% 2627
2022
Q2
$18.8M Buy
1,193,656
+40,143
+3% +$788K ﹤0.01% 2669
2022
Q1
$31.1M Buy
1,153,513
+6,291
+0.5% +$161K ﹤0.01% 2545
2021
Q4
$42.5M Buy
1,147,222
+33,271
+3% +$1.36M ﹤0.01% 2450
2021
Q3
$53.2M Sell
1,113,951
-65,890
-6% -$2.95M ﹤0.01% 2326
2021
Q2
$39.9M Sell
1,179,841
-17,539
-1% -$594K ﹤0.01% 2487
2021
Q1
$49.5M Buy
1,197,380
+14,998
+1% +$894K ﹤0.01% 2324
2020
Q4
$51.3M Buy
1,182,382
+145,205
+14% +$9.83M ﹤0.01% 2189
2020
Q3
$44.5M Buy
1,037,177
+166,242
+19% +$8.25M ﹤0.01% 2074
2020
Q2
$40.7M Buy
870,935
+727,354
+507% +$25.1M ﹤0.01% 2104
2020
Q1
$1.95M Buy
143,581
+19,700
+16% +$252K ﹤0.01% 3321
2019
Q4
$1.35M Hold
123,881
﹤0.01% 3554
2019
Q3
$1.27M Buy
+123,881
New +$1.34M ﹤0.01% 3579

Other funds holding ARCT